Zobrazeno 1 - 10
of 234
pro vyhledávání: '"Patrick Davey"'
Autor:
Mary Kirk
Publikováno v:
Journal of Renal Care. 35:220-220
Autor:
David Sines
Publikováno v:
Nursing Standard. 17:29-29
Autor:
Kyriacos Alexandrou, Patrick Davey
Publikováno v:
International Journal of Clinical Practice. 2022:1-13
Background: Cardiovascular disease (CVD) is a common co-morbidity in patients with prostate cancer. In this review, we summarise the published literature on the association of cardiovascular risk with androgen deprivation therapy (ADT) treatment and
Autor:
Patrick Davey, Brett M Paterson
Publikováno v:
Molecules (Basel, Switzerland). 28(1)
The positron-emitting radionuclide gallium-68 has become increasingly utilised in both preclinical and clinical settings with positron emission tomography (PET). The synthesis of radiochemically pure gallium-68 radiopharmaceuticals relies on careful
Publikováno v:
BJPsych Open, Vol 2, Pp 244-246 (2016)
A case is presented of a 25-year-old man with treatment-resistant paranoid schizophrenia whose only previous trial of clozapine had been stopped following a suspected clozapine-induced myocarditis. Due to the failure of his psychosis to respond to a
Externí odkaz:
https://doaj.org/article/a2e4d9bdc88a4771b58fde436c33da80
Autor:
Patrick Davey, Michael G Kirby
Publikováno v:
World Journal of Urology
Purpose Androgen deprivation therapy (ADT) is the mainstay for the management of metastatic prostate cancer. Available pharmaceutical ADTs include gonadotropin-releasing hormone (GnRH) agonists and antagonists. Here, real-world data are presented fro
Publikováno v:
BJPsych Open. 8:S100-S100
AimsThe Tony Hillis Unit (THU) is a locked rehabilitation unit for men aged 18–65 years with Treatment Resistant Psychosis, with or without mild personality disorders; drug and alcohol misuse; and challenging behaviour. The multi-disciplinary team
Autor:
Patrick Davey, Mike G. Kirby
Publikováno v:
World Journal of Urology. 40:1603-1603
PD10-12 CARDIOVASCULAR RISK WITH GNRH AGONISTS AND ANTAGONISTS: REAL-WORLD DATA FROM UK PRIMARY CARE
Autor:
Patrick Davey, Mike Kirby
Publikováno v:
Journal of Urology. 203
INTRODUCTION AND OBJECTIVE:Androgen deprivation therapy (ADT) is used as a treatment for prostate cancer which aims to reduce serum testosterone to castrate levels. Gonadotrophin releasing hormone ...
Autor:
Jill R. Cuni, Ilene S. Ruhoy, Emma J. Reinhold, Stephanie J. Kratzer, Peter C. Rowe, Ariana D. Buchanan, Mark Westaway, Laurie Radovsky, William Patrick Davey, Andrew J. Maxwell, William A. Robinson, Martina Wengenroth, Kimberly J. Hindman, Jill R. Schofield, David L. Kaufman, Mindy S. Marantz, David A. Schlosser, Dahra D. Perkins, Dwight L. McKee, Jill B Brook, E. Scott Rosenbloom, Leonard B. Weinstock, Laura A. Pace, Alena G. Guggenheim, Sonia A. Rapaport, Mark Renneker, Gerhard J. Molderings, Linda S. Bluestein, Martin S. Dubravec, Tania T. Dempsey, Joseph H. Brewer, Shanda R. Dorff, Aaron M. Roland, Mary B. Ackerley, Shijun Cindy Xi, Janet E. Settle, Bruce Hoffman, Lawrence B. Afrin, Kelly K. McCann, David S. Saperstein, Laurie Menk Otto, Theodore M. Lee, Mary S. Raleigh
Publikováno v:
Diagnosis (Berlin, Germany)References. 8(2)
The concept that disease rooted principally in chronic aberrant constitutive and reactive activation of mast cells (MCs), without the gross MC neoplasia in mastocytosis, first emerged in the 1980s, but only in the last decade has recognition of “ma